Moreover, the oral administration of the insulin-bearing recombinant GM4-ΔTS-PGK1-CCT-insulin strain in type II diabetes mellitus mice significantly reduced blood glucose levels in vivo, indicating that the recombinant strain we constructed successfully carries the exogenous polypeptide into the body. Here, PGK1 is linked to type 2 diabetes mellitus.